Old Web
English
Sign In
Acemap
>
authorDetail
>
Mike R. Russell
Mike R. Russell
Janssen Pharmaceutica
Prostate cancer
Cancer research
Medicine
castration resistant
Castration
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pretherapeutic first-in-human targeting trial of anti-hK2 antibody h11B6: A potential molecular vector for alpha-particle radioimmunotherapy.
2021
Journal of Clinical Oncology
Michael J. Morris
Joseph A. O’Donoghue
Dushen Chetty
Steven Max
Danielle Wanik
Mike R. Russell
Tenzin Nyima
Anjali Narayan Avadhani
Chaitanya R. Divgi
Neeta Pandit-Taskar
Show All
Source
Cite
Save
Citations (0)
Phase 0 study to assess [111In]-DOTA-h11B6 to target human kallikrein-2 (hk2) in men with metastatic castration-resistant prostate cancer.
2020
Journal of Clinical Oncology
Michael J. Morris
Joseph A. O’Donoghue
Dushen Chetty
Mike R. Russell
Emma Zulch
Anjali Narayan Avadhani
Chaitanya Divgi
Neeta Pandit-Taskar
Show All
Source
Cite
Save
Citations (0)
1